publication date: Nov. 6, 2020

NCI Trials

NCI Trials for Nov. 2020

The National Cancer Institute approved the following clinical research studies last month. 

For further information, contact the principal investigator listed.


Phase I – PED-CITN-01

3CI Study: Childhood Cancer Combination Immunotherapy. Phase Ib and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers

Cancer Immunotherapy Trials Network

Morgenstern, Daniel Alexander

(416) 813-7654


Phase II – A021804

A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma

Alliance for Clinical Trials in Oncology

Del Rivero, Jaydira

(240) 805-2888


Phase II – AMC-107

A Phase 2 Trial of Ixazomib for Kaposi Sarcoma

AIDS Malignancy Consortium

Mitsuyasu, Ronald T.

(310) 825-6689


Phase II – EA8184

A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers

ECOG-ACRIN Cancer Research Group

Kumar, Nagi B.

(813) 745-6885


Phase III – EA9181

A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

ECOG-ACRIN Cancer Research Group

Ofran, Yishai



Phase III – EAA181

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation

ECOG-ACRIN Cancer Research Group

Kumar, Shaji K.

(507) 284-2017


Phase III – NRG-BN009

Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for First or Second Distant Brain Relapse After Upfront SRS with Brain Metastasis Velocity >/= 4 Brain Metastases/Year

NRG Oncology

Gondi, Vinai

(630) 821-6430


Phase Other – A231901CD

Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHADES)

Alliance for Clinical Trials in Oncology

Hawley, Sarah

(734) 936-8816

Copyright (c) 2020 The Cancer Letter Inc.